Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna

Dicerna Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended , in connection with Novo Nordisk’s cash tender... | December 25, 2021

Related Keywords

New York ,United States ,Dicerna Gal ,Eli Lilly ,Novo Nordisk ,Boehringer Ingelheim International Gmb ,Alexion Pharmaceuticals Inc ,Alnylam Pharmaceuticals Inc ,Nasdaq ,Dicerna Pharmaceuticals Inc ,Dicerna Pharmaceuticals ,Hart Scott Rodino Antitrust Improvements Act ,Eastern Time ,Alexion Pharmaceuticals ,Boehringer Ingelheim International Gmbh ,Alnylam Pharmaceuticals ,Between Dicerna ,Registration Statement ,Quarterly Report ,Current Reports ,Tender Offer Statement ,Recommendation Statement ,Nc Stock Exchange ,News ,Information ,Press Release ,Icerna ,Oday ,Nnounced ,Hat ,The ,Waiting ,Eriod ,Under ,Antitrust ,Improvements ,Fact ,F ,Us ,Amended ,N ,Connection ,Ith ,Uovo ,Ash Drna Us2530311081 ,